CERAPP: collaborative estrogen receptor activity prediction project K Mansouri, A Abdelaziz, A Rybacka, A Roncaglioni, A Tropsha, A Varnek, ... Environmental health perspectives 124 (7), 1023-1033, 2016 | 312 | 2016 |
Applicability domains for classification problems: benchmarking of distance to models for Ames mutagenicity set I Sushko, S Novotarskyi, R Körner, AK Pandey, A Cherkasov, J Li, ... Journal of chemical information and modeling 50 (12), 2094-2111, 2010 | 253 | 2010 |
Predicting ADME properties and side effects: the BioPrint approach CM Krejsa, D Horvath, SL Rogalski, JE Penzotti, B Mao, F Barbosa, ... Current opinion in drug discovery and development 6 (4), 470-480, 2003 | 251 | 2003 |
ISIDA-Platform for virtual screening based on fragment and pharmacophoric descriptors A Varnek, D Fourches, D Horvath, O Klimchuk, C Gaudin, P Vayer, ... Current Computer-Aided Drug Design 4 (3), 191, 2008 | 249 | 2008 |
Predicting the predictability: a unified approach to the applicability domain problem of QSAR models H Dragos, M Gilles, V Alexandre Journal of chemical information and modeling 49 (7), 1762-1776, 2009 | 196 | 2009 |
A virtual screening approach applied to the search for trypanothione reductase inhibitors D Horvath Journal of medicinal chemistry 40 (15), 2412-2423, 1997 | 186 | 1997 |
Generative topographic mapping (GTM): universal tool for data visualization, structure‐activity modeling and dataset comparison N Kireeva, II Baskin, HA Gaspar, D Horvath, G Marcou, A Varnek Molecular informatics 31 (3‐4), 301-312, 2012 | 155 | 2012 |
ISIDA Property‐Labelled Fragment Descriptors F Ruggiu, G Marcou, A Varnek, D Horvath Molecular informatics 29 (12), 855-868, 2010 | 151 | 2010 |
CoMPARA: collaborative modeling project for androgen receptor activity K Mansouri, N Kleinstreuer, AM Abdelaziz, D Alberga, VM Alves, ... Environmental Health Perspectives 128 (2), 027002, 2020 | 138 | 2020 |
De novo molecular design by combining deep autoencoder recurrent neural networks with generative topographic mapping B Sattarov, II Baskin, D Horvath, G Marcou, EJ Bjerrum, A Varnek Journal of chemical information and modeling 59 (3), 1182-1196, 2019 | 137 | 2019 |
Neighborhood behavior of in silico structural spaces with respect to in vitro activity spaces− A novel understanding of the molecular similarity principle in the context of … D Horvath, C Jeandenans Journal of chemical information and computer sciences 43 (2), 680-690, 2003 | 111 | 2003 |
Chemical data visualization and analysis with incremental generative topographic mapping: big data challenge HA Gaspar, II Baskin, G Marcou, D Horvath, A Varnek Journal of chemical information and modeling 55 (1), 84-94, 2015 | 109 | 2015 |
Pharmacophore-based virtual screening D Horvath Chemoinformatics and computational chemical biology, 261-298, 2011 | 108 | 2011 |
Pin1: a therapeutic target in Alzheimer neurodegeneration M Hamdane, C Smet, AV Sambo, A Leroy, JM Wieruszeski, P Delobel, ... Journal of molecular neuroscience 19, 275-287, 2002 | 93 | 2002 |
Expert system for predicting reaction conditions: the Michael reaction case G Marcou, J Aires de Sousa, DARS Latino, A de Luca, D Horvath, ... Journal of chemical information and modeling 55 (2), 239-250, 2015 | 87 | 2015 |
Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes F Bonachéra, B Parent, F Barbosa, N Froloff, D Horvath Journal of chemical information and modeling 46 (6), 2457-2477, 2006 | 84 | 2006 |
GTM‐Based QSAR Models and Their Applicability Domains HA Gaspar, II Baskin, G Marcou, D Horvath, A Varnek Molecular informatics 34 (6‐7), 348-356, 2015 | 75 | 2015 |
An evolutionary optimizer of libsvm models D Horvath, JB Brown, G Marcou, A Varnek Challenges 5 (2), 450-472, 2014 | 71 | 2014 |
Generative topographic mapping-based classification models and their applicability domain: Application to the biopharmaceutics drug disposition classification system (BDDCS) HA Gaspar, G Marcou, D Horvath, A Arault, S Lozano, P Vayer, A Varnek Journal of chemical information and modeling 53 (12), 3318-3325, 2013 | 71 | 2013 |
Evolution of commercially available compounds for HTS DM Volochnyuk, SV Ryabukhin, YS Moroz, O Savych, A Chuprina, ... Drug Discovery Today 24 (2), 390-402, 2019 | 70 | 2019 |